Coronary/Structural Heart

Nuwellis Announces IRB Approval to Begin Its REVERSE-HF Clinical Study

The REVERSE-HF study will evaluate ultrafiltration therapy for heart failure patients suffering from fluid overload MINNEAPOLIS, March 15, 2022 (GLOBE NEWSWIRE) — Nuwellis, Inc. (Nasdaq: NUWE) today announced it has received independent Institutional Review Board (IRB) approval for the trial protocol of the company’s REVERSE-HF (Ultrafiltration Versus IV Diuretics in Worsening Heart Failure) clinical study […]

Evidation, VA Collaborate to Enroll Veterans in Personalized Heart Health Program

App-based program was co-developed by Evidation and the American College of Cardiology WASHINGTON & SAN MATEO, Calif.–(BUSINESS WIRE)–Evidation and the Department of Veterans Affairs and the Veterans Health Administration Innovation Ecosystem (VHAIE) announced today an initiative to enroll Veterans in Heart Health on Evidation—a specialized heart health program built on […]

Impulse Dynamics Announces First Patient Enrolled in AIM HIGHer — Implantable Device Trial to Treat Heart Failure in Higher EF Population

Trial Evaluates FDA-Designated Breakthrough Therapy for Patients Who Lack Treatment Options MARLTON, N.J., March 14, 2022 (GLOBE NEWSWIRE) — Impulse Dynamics, a global medical device company dedicated to improving the lives of people with heart failure (HF), today announced that the first patient has been enrolled in the quadruple-blinded sham-controlled […]

Latest analysis shows VASCEPA® (icosapent ethyl) significantly lowered the risk of potentially fatal cardiovascular events in patients with prior percutaneous coronary intervention

A new post hoc sub-analysis of the landmark REDUCE-IT Study, published in the Journal of the American Heart Association (JAHA), found VASCEPA® significantly reduced the risk of cardiovascular death, strokes, heart attacks, coronary revascularization, and unstable angina by 34% in patients with a history of percutaneous coronary intervention (PCI).(1) Icosapent ethyl […]

Medical Ingenuities Conducts First Commercial Cases with Transformational Radial Hemostasis Band System to Achieve Patent Hemostasis

Key Radial Surgeon conducts 4 successful percutaneous coronary interventional (PCI) cases at Lakewood Ranch Medical Center with Medical Ingenuities PH Band System. The PH Band System meets SCAI’s Guidelines by achieving patent hemostasis. WHEATON, Ill. , March 9, 2022 /PRNewswire/ — On February 21st, board-certified cardiologist, Dr. Vivek V. Kumar, completed 4 radial cases at […]

Vicore strengthens rare lung disease pipeline with PAH indication

– Strong preclinical data shows that C21 reverses vascular remodelling – Proof-of-concept trial in pulmonary arterial hypertension (“PAH”) planned to start late 2022 – Appointment of two new senior clinical advisors in PAH GOTHENBURG, Sweden, March 9, 2022 /PRNewswire/ — Vicore Pharma Holding AB (publ) (“Vicore”), a clinical-stage pharmaceutical company developing medicines targeting […]

Mobile Cardiac Testing Unit Saves the Lives of Four Elizabeth Police Department Officers

Advanced Cardiovascular Diagnostics Identifies Officers Who Needed Live-Saving Care ELIZABETH, N.J., March 9, 2022 /PRNewswire/ — On February 23rd and 24th, the Advanced Cardiovascular Diagnostic (ACD) Mobile Testing Unit performed cardio stress testing for the Police Officers of the Elizabeth, New Jersey Police Department. ACD tested approximately 60 members of their Department. During the examination period, the medical staff […]

Shockwave Medical Named to Fast Company’s “Most Innovative Company” List

Pioneer of IVL Selected as the Second Most Innovative Medical Device Company SANTA CLARA, Calif., March 08, 2022 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular disease, has been named in Fast Company’s 2022 list of the World’s […]

Dascena Awarded NIH Grant to Reduce Bias in Acute Coronary Syndrome Diagnosis and Treatment

Latest grant is the 9th awarded to Dascena from the National Institute of Health SAN FRANCISCO–(BUSINESS WIRE)–Dascena, a developer of machine learning diagnostic algorithms to enable early disease intervention and improved care outcomes for patients, has received a grant from the National Institute on Minority Health and Health Disparities (part of the National […]